tirzepatide 中国 FDA批准糖尿病药物Mounjaro以品牌名Zepbound用于减肥- 科技- 福布斯中国| Forbes China 东亚前海证券]:创新药行业周报:礼来GLP-1R/GIP双靶点减肥药Tirzepatide中国III期研究获得成功,建议积极布局减肥药蓝海市场
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
![tirzepatide FDAMounjaroZepbound- - | Forbes China ]GLP-1R/GIPTirzepatideIII](https://public.fxbaogao.com/report-image/2023/02/13/3565978-1.png?x-oss-process=image/format,webp)
![tirzepatide FDAMounjaroZepbound- - | Forbes China ]GLP-1R/GIPTirzepatideIII](https://www.china-sinoway.com/uploadfile/202507/16/5525fab9fc6800b674bedd575ee7abc2_medium.jpg)
![tirzepatide FDAMounjaroZepbound- - | Forbes China ]GLP-1R/GIPTirzepatideIII](https://m.chemicalbook.com/ProductImageEN/2024-04/Large/f447620e-429a-4841-b2ef-fd44cd92c4e4.jpg)
![tirzepatide FDAMounjaroZepbound- - | Forbes China ]GLP-1R/GIPTirzepatideIII](http://www.taobaodrug.com/zb_users/upload/2025/10/202510281761649280454553.png)
![tirzepatide FDAMounjaroZepbound- - | Forbes China ]GLP-1R/GIPTirzepatideIII](https://q0.itc.cn/images01/20240723/a3c088da71684ef1be33e3b7b1da4258.png)























